Literature DB >> 25367905

Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.

Soon-Ee Cheah1, Jian Li1, Roger L Nation2, Jürgen B Bulitta2.   

Abstract

In vitro static concentration time-kill (SCTK) studies are a cornerstone for antibiotic development and designing dosage regimens. However, mathematical approaches to efficiently model SCTK curves are scarce. The currently used model-free, descriptive metrics include the log10 change in CFU from 0 h to a defined time and the area under the viable count versus time curve. These metrics have significant limitations, as they do not characterize the rates of bacterial killing and regrowth and lack sensitivity. Our aims were to develop a novel rate-area-shape modeling approach and to compare, against model-free metrics, its relative ability to characterize the rate, extent, and timing of bacterial killing and regrowth from SCTK studies. The rate-area-shape model and the model-free metrics were applied to data for colistin and doripenem against six Acinetobacter baumannii strains. Both approaches identified exposure-response relationships from 0.5- to 64-fold the MIC. The model-based approach estimated an at least 10-fold faster killing by colistin than by doripenem at all multiples of the MIC. However, bacterial regrowth was more extensive (by 2 log10) and occurred approximately 3 h earlier for colistin than for doripenem. The model-free metrics could not consistently differentiate the rate and extent of killing between colistin and doripenem. The time to 2 log10 killing was substantially faster for colistin. The rate-area-shape model was successfully implemented in Excel. This new model provides an improved framework to distinguish between antibiotics with different rates of bacterial killing and regrowth and will enable researchers to better characterize SCTK experiments and design subsequent dynamic studies.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367905      PMCID: PMC4291376          DOI: 10.1128/AAC.04182-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

Review 1.  Dosing of colistin-back to basic PK/PD.

Authors:  Phillip J Bergen; Jian Li; Roger L Nation
Journal:  Curr Opin Pharmacol       Date:  2011-08-09       Impact factor: 5.547

2.  In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin.

Authors:  Céline Vidaillac; Jorge Parra-Ruiz; Michael Joseph Rybak
Journal:  Diagn Microbiol Infect Dis       Date:  2011-10-21       Impact factor: 2.803

3.  Environment. Looming global-scale failures and missing institutions.

Authors:  Brian Walker; Scott Barrett; Stephen Polasky; Victor Galaz; Carl Folke; Gustav Engström; Frank Ackerman; Ken Arrow; Stephen Carpenter; Kanchan Chopra; Gretchen Daily; Paul Ehrlich; Terry Hughes; Nils Kautsky; Simon Levin; Karl-Göran Mäler; Jason Shogren; Jeff Vincent; Tasos Xepapadeas; Aart de Zeeuw
Journal:  Science       Date:  2009-09-11       Impact factor: 47.728

Review 4.  Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.

Authors:  Johan W Mouton; Paul G Ambrose; Rafael Canton; George L Drusano; Stephan Harbarth; Alasdair MacGowan; Ursula Theuretzbacher; John Turnidge
Journal:  Drug Resist Updat       Date:  2011-03-26       Impact factor: 18.500

Review 5.  Optimizing dosage to prevent emergence of resistance - lessons from in vitro models.

Authors:  Renu Singh; Vincent H Tam
Journal:  Curr Opin Pharmacol       Date:  2011-08-23       Impact factor: 5.547

6.  Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae.

Authors:  Mahableshwar Albur; Alan Noel; Karen Bowker; Alasdair MacGowan
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

7.  Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead.

Authors:  Brian T Tsuji; Olanrewaju O Okusanya; Jurgen B Bulitta; Alan Forrest; Sujata M Bhavnani; Prabha B Fernandez; Paul G Ambrose
Journal:  Clin Infect Dis       Date:  2011-06       Impact factor: 9.079

8.  Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia.

Authors:  Yoriko Harigaya; Jürgen B Bulitta; Alan Forrest; George Sakoulas; Alan J Lesse; Joseph M Mylotte; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

9.  In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore.

Authors:  Tze-Peng Lim; Thean-Yen Tan; Winnie Lee; S Sasikala; Thuan-Tong Tan; Li-Yang Hsu; Andrea L Kwa
Journal:  PLoS One       Date:  2011-04-21       Impact factor: 3.240

10.  Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B.

Authors:  Tze-Peng Lim; Winnie Lee; Thean-Yen Tan; Suranthran Sasikala; Jocelyn Teo; Li-Yang Hsu; Thuan-Tong Tan; Nur Syahidah; Andrea L Kwa
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

View more
  5 in total

1.  Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.

Authors:  Nusaibah Abdul Rahim; Soon-Ee Cheah; Matthew D Johnson; Heidi Yu; Hanna E Sidjabat; John Boyce; Mark S Butler; Matthew A Cooper; Jing Fu; David L Paterson; Roger L Nation; Phillip J Bergen; Tony Velkov; Jian Li
Journal:  J Antimicrob Chemother       Date:  2015-05-28       Impact factor: 5.790

2.  Antibacterial activity and mode of action of totarol against Staphylococcus aureus in carrot juice.

Authors:  Ce Shi; Meiyao Che; Xiaowei Zhang; Zuojia Liu; Rizeng Meng; Xiujuan Bu; Haiqing Ye; Na Guo
Journal:  J Food Sci Technol       Date:  2018-02-03       Impact factor: 2.701

Review 3.  Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.

Authors:  Jürgen B Bulitta; William W Hope; Ann E Eakin; Tina Guina; Vincent H Tam; Arnold Louie; George L Drusano; Jennifer L Hoover
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

4.  Antimicrobial, antioxidant, and antitumor activity of epsilon-poly-L-lysine and citral, alone or in combination.

Authors:  Ce Shi; Xingchen Zhao; Zonghui Liu; Rizeng Meng; Xiangrong Chen; Na Guo
Journal:  Food Nutr Res       Date:  2016-06-15       Impact factor: 3.894

5.  Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.

Authors:  Thien B Tran; Soon-Ee Cheah; Heidi H Yu; Phillip J Bergen; Roger L Nation; Darren J Creek; Anthony Purcell; Alan Forrest; Yohei Doi; Jiangning Song; Tony Velkov; Jian Li
Journal:  J Antibiot (Tokyo)       Date:  2015-12-16       Impact factor: 2.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.